Kayyem Jon Faiz

CIK 00013662686 companiesLOUISVILLE, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001366268

Recent Transactions

50 trades

Award
BIODESIX INC$BDSX
Restricted Stock Units
2026-01-02+5,443→ 5,443 total
Award
BIODESIX INC$BDSX
Stock Options (Right to Buy)
2026-01-02+6,354→ 6,354 total
Award
Inhibrx Biosciences, Inc.$INBX
Stock Option (right to buy)
2025-05-28+15,000→ 15,000 total
Award
BIODESIX INC$BDSX
Stock Options (Right to Buy)
2025-05-20+42,010→ 42,010 total
Award
BIODESIX INC$BDSX
Restricted Stock Units
2025-05-20+68,621→ 68,621 total
Gift
Inhibrx Biosciences, Inc.$INBX
Common Stock
2025-03-27−90,000→ 419,360 total
Gift
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-12-16+250,000→ 250,000 total
Gift
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-12-16−500,000→ 509,360 total
Gift
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-12-16+250,000→ 250,000 total
Gift
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-12-06−52,000→ 1,009,360 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-11-20$14.19/sh+18,750→ 69,843 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-11-20$14.19/sh+18,750→ 69,843 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-11-19$14.23/sh+34,843→ 51,093 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-11-19$14.23/sh+34,843→ 51,093 total
Gift
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-24−89,050→ 1,061,360 total
Gift
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-24+10,000→ 16,250 total
Gift
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-24+10,000→ 16,250 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-05$17.89/sh+8,265→ 1,150,410 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-05$17.23/sh+49,284→ 1,142,145 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-04$18.24/sh+23,726→ 1,092,861 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-04$17.44/sh+65,337→ 1,069,135 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-03$17.90/sh+80,738→ 1,003,798 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-06-03$16.61/sh+46,792→ 923,060 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-05-31$16.14/sh+70,193→ 876,268 total
Award
Inhibrx Biosciences, Inc.$INBX
Stock Option (right to buy)
2024-05-30+30,000→ 30,000 total
Disposition to Issuer
Inhibrx, Inc.
Common Stock
2024-05-30$30.00/sh−3,224,301→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Common Stock
2024-05-30$30.00/sh−25,000→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Stock Option (right to buy)
2024-05-30−15,000→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Common Stock
2024-05-30$30.00/sh−25,000→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Stock Option (right to buy)
2024-05-30−15,000→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Stock Option (right to buy)
2024-05-30−17,259→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Stock Option (right to buy)
2024-05-30−15,000→ 0 total
Award
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-05-29+806,075→ 806,075 total
Award
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-05-29+6,250→ 6,250 total
Award
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-05-29+6,250→ 6,250 total
Award
BIODESIX INC$BDSX
Restricted Stock Units
2024-05-21+46,686→ 46,686 total
Award
BIODESIX INC$BDSX
Stock Options (Right to Buy)
2024-05-21+37,050→ 37,050 total
Award
BIODESIX INC$BDSX
Restricted Stock Units
2024-01-01+105,389→ 134,262 total
Award
BIODESIX INC$BDSX
Common Stock
2023-08-03$1.62/sh+6,172→ 180,085 total
Award
Inhibrx, Inc.
Stock Option (right to buy)
2023-05-25+15,000→ 15,000 total
Award
BIODESIX INC$BDSX
Restricted Stock Units
2023-05-23+28,873→ 28,873 total
Exercise/Conversion
BIODESIX INC$BDSX
Common Stock
2023-03-31+145,833→ 177,452 total
Exercise/Conversion
BIODESIX INC$BDSX
Restricted Stock Units
2023-03-31−145,833→ 4,878 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.26/sh−9,500→ 3,224,301 total
Award
BIODESIX INC$BDSX
Restricted Stock Units
2023-01-03+4,878→ 150,711 total
Award
BIODESIX INC$BDSX
Restricted Stock Units
2023-01-01+62,500→ 145,833 total
Exercise/Conversion
BIODESIX INC$BDSX
Common Stock
2022-12-21+31,619→ 31,619 total
Exercise/Conversion
BIODESIX INC$BDSX
Restricted Stock Units
2022-12-21−31,619→ 0 total
Sale
Inhibrx, Inc.
Common Stock
2022-12-21$26.87/sh−7,541→ 3,235,760 total
Sale
Inhibrx, Inc.
Common Stock
2022-12-21$27.61/sh−1,959→ 3,233,801 total

Companies

Recent Filings

Address

919 WEST DILLON RD

LOUISVILLE, CO, 80027

View on SEC.gov